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Materials and Methods Introduction
The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6
Results 454 untreated OSA patients had a sleep study, magnetic resonance imaging (MRI) for total abdominal and visceral fat volume (Figure 3) , and had fasting morning IL-6 and CRP levels in serum measured. A multiple linear regression model with higher order and interaction terms was performed to estimate the interaction between OSA severity and obesity on IL-6 and CRP levels.
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Obesity and obstructive sleep apnea (OSA, Figure 1 ) commonly coexist and have many shared pathways such as inflammation (Figure 2) . The aim of the study was to investigate the relevant effect of OSA and obesity on interleukin-6 (IL-6) and C-reactive protein (CRP) levels. Also to assess if the effect of OSA on IL-6 and leptin differs by the degree of obesity.
•OSA severity is an independent predictor of levels of IL-6 and CRP but interacts with obesity such that this association is found only in obese subjects.
•In nonobese subjects, there is no association of IL-6 and CRP levels with OSA severity.
• BMI, a total fat measure, predicts IL-6 and leptin levels better than visceral fat.
Demographics
The untreated OSA patients (n=454) included in this study had a mean±SD age of 54.4±10.6 yrs, mean BMI 32.6±5.3 kg/m 2 , mean apnea hypopnea index (AHI) 40.1±16.1 events/hour and mean oxygen desaturation index (ODI) 31.5±14.0 events/hour. 84% of the cohort was male. Subjects were divided into 3 BMI tertiles, BMI<30 (n=158), BMI 30-35 (n=163) and BMI>35 (n=133). See Inflammatory biomarkers, obesity and OSA severity A significantly higher correlation was found for BMI than visceral fat volume with CRP and IL-6 levels (bootstrap analysis). Oxygen desaturation index, hypoxia time and minimum SaO 2 significantly correlated with IL-6 and CRP levels, but apnea hypopnea index did not. When stratified by BMI category, OSA severity was associated with IL-6 and CRP levels in obese subjects only ( Figure 5 ).
Conclusion Figure 6:
Three-dimensional plots for IL-6 levels as a function of BMI and four OSA severity measures: a) apneahypopnea index (AHI); b) oxygen desaturation index (ODI); c) hypoxia time (minutes with SaO 2 <90%) and d) minimum SaO 2.
Response surface modeling for IL-6 and CRP
A multiple linear regression model with interaction terms showed an independent association of OSA severity with IL-6 levels and an interaction between OSA severity and BMI, i.e., degree of obesity altered the relationship between OSA and IL-6 levels ( Figure 6 ). An independent association of OSA severity with CRP levels was found for minimum SaO 2 only, not the other OSA severity indices. A similar interaction of minimum SaO 2 and BMI on CRP levels was found for males and postmenopausal women.
Models with visceral fat explained much less of biomarker variance than models with BMI. 
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Figure 4:
The study cohort.
